Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
Onco-Haematology Department, Hôpital Saint Louis, Paris 7 university, Paris, France.
Camille
C
Bigenwald
Onco-Haematology Department, Hôpital Saint Louis, Paris 7 university, Paris, France.
Stéphanie
S
Harel
Haematology Department, Hôpital Avicenne, Paris 13 university, Paris, France.
Florian
F
Chevignon
Inserm U985, Institut Gustave Roussy, Villejuif, France.
Damien
D
Roos-Weil
Inserm U985, Institut Gustave Roussy, Villejuif, France.
Olivier A
OA
Bernard
Onco-Haematology Department, Hôpital Saint Louis, Paris 7 university, Paris, France.
Sandy
S
Amorim
Onco-Haematology Department, Hôpital Saint Louis, Paris 7 university, Paris, France.
Pauline
P
Brice
Senior Haematology Department, Hôpital Saint Louis, Paris 7 university, Paris, France.
Lionel
L
Adès
Senior Haematology Department, Hôpital Saint Louis, Paris 7 university, Paris, France.
Anne Marie
AM
Nloga
Senior Haematology Department, Hôpital Saint Louis, Paris 7 university, Paris, France.
Marie
M
Sébert
Haematology Department, Hôpital Avicenne, Paris 13 university, Paris, France.
Thorsten
T
Braun
Haematology Biology Department, Hôpital Avicenne, Paris 13 university, Paris, France.
Virginie
V
Eclache
Onco-Haematology Department, Hôpital Saint Louis, Paris 7 university, Paris, France.
Catherine
C
Thieblemont
Senior Haematology Department, Hôpital Saint Louis, Paris 7 university, Paris, France.
Pierre
P
Fenaux
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000009:adverse effects / Q000379:methods; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality; D008223:Lymphoma / Q000401:mortality / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality; D016609:Neoplasms, Second Primary; D063868:Patient Outcome Assessment; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods
acute myeloid leukaemia; lymphomas; myelodysplastic syndrome; therapy-related